Literature DB >> 35357548

Regression patterns of central serous chorioretinopathy using en face optical coherence tomography.

Supriya Arora1, Brian Rosario2, Abdul Rasheed Mohammed3, Oliver Beale2, Amrish Selvam2, Ramesh Venkatesh4, Dmitrii S Maltsev5, Jay Chhablani6.   

Abstract

PURPOSE: To study the regression patterns of subretinal fluid (SRF) in central serous chorioretinopathy (CSCR) on sequential en face optical coherence tomography (OCT) and its relationship to leak locations.
METHODS: Retrospective study on patients with acute CSCR. Inclusion criteria were (i) availability of data, sequential OCT and OCT angiography (B scan and en face OCT) every 2 weeks until resolution of SRF or 6 months, whichever is earlier; (ii) single active leak. Exclusion criteria were (i) presence of macular neovascularization or atypical CSCR, (ii) diffuse pigment epitheliopathy, (iii) multiple leaks. Serial en face OCT scans were evaluated and the area of SRF was measured using ImageJ software. Correlation coefficient was calculated for the regression rate of SRF area and central retinal thickness (CRT) over the first month of follow-up and the time of complete SRF resolution.
RESULTS: Out of the 25 eyes, 20 eyes demonstrated a centripetal regression, and 5 eyes demonstrated a centrifugal regression. In eyes with a leakage point <1000μ from the fovea, 86% resolved in a centripetal fashion, and in eyes with leak site ≥1000μ away from fovea, 70% eyes resolved centripetally. There was a correlation (r=-0.47, p=0.018) of the rate regression of SRF area during the first month and timing of resolution. In contrast, this correlation was absent (r=-0.16, p=0.44) for CRT regression.
CONCLUSION: Our en face-based analysis of sequential OCTs of regressing CSCR demonstrated a tendency for the subfoveal SRF to resolve towards the end or a centripetal pattern of regression. Prediction of resolution of SRF at 1 month is better with en face area of SRF in comparison to CRT.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Central serous chorioretinopathy; En face imaging; Regression pattern; Subretinal fluid

Mesh:

Year:  2022        PMID: 35357548     DOI: 10.1007/s00417-022-05636-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  10 in total

1.  Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.

Authors:  Serra Arf; Mumin Hocaoglu; Isil Sayman Muslubas; Murat Karacorlu
Journal:  Int Ophthalmol       Date:  2016-07-08       Impact factor: 2.031

2.  Experience with nontreatment of central serous choroidopathy.

Authors:  M L Klein; E M Van Buskirk; E Friedman; E Gragoudas; S Chandra
Journal:  Arch Ophthalmol       Date:  1974-04

3.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

4.  Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy.

Authors:  Sarah Mrejen; Chandrakumar Balaratnasingam; Talia R Kaden; Alexander Bottini; Kunal Dansingani; Kavita V Bhavsar; Nicolas A Yannuzzi; Samir Patel; Kevin C Chen; Suqin Yu; Guillaume Stoffels; Richard F Spaide; K Bailey Freund; Lawrence A Yannuzzi
Journal:  Ophthalmology       Date:  2019-01-17       Impact factor: 12.079

Review 5.  Central serous chorioretinopathy: Towards an evidence-based treatment guideline.

Authors:  Thomas J van Rijssen; Elon H C van Dijk; Suzanne Yzer; Kyoko Ohno-Matsui; Jan E E Keunen; Reinier O Schlingemann; Sobha Sivaprasad; Giuseppe Querques; Susan M Downes; Sascha Fauser; Carel B Hoyng; Felice Cardillo Piccolino; Jay K Chhablani; Timothy Y Y Lai; Andrew J Lotery; Michael Larsen; Frank G Holz; K Bailey Freund; Lawrence A Yannuzzi; Camiel J F Boon
Journal:  Prog Retin Eye Res       Date:  2019-07-15       Impact factor: 21.198

6.  Choroidal Changes at the Leakage Site in Acute Central Serous Chorioretinopathy.

Authors:  Niroj Kumar Sahoo; Dmitrii S Maltsev; Abhilash Goud; Alexei N Kulikov; Jay Chhablani
Journal:  Semin Ophthalmol       Date:  2019-06-29       Impact factor: 1.975

7.  Long-term results of focal laser photocoagulation and photodynamic therapy for the treatment of central serous chorioretinopathy.

Authors:  Yong-Il Shin; Kyeung-Min Kim; Min-Woo Lee; Jung-Yeul Kim; Young-Joon Jo
Journal:  Jpn J Ophthalmol       Date:  2019-12-20       Impact factor: 2.447

8.  Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.

Authors:  Andrew Lotery; Sobha Sivaprasad; Abby O'Connell; Rosie A Harris; Lucy Culliford; Lucy Ellis; Angela Cree; Savita Madhusudhan; Francine Behar-Cohen; Usha Chakravarthy; Tunde Peto; Chris A Rogers; Barnaby C Reeves
Journal:  Lancet       Date:  2020-01-25       Impact factor: 79.321

9.  A Method for En Face OCT Imaging of Subretinal Fluid in Age-Related Macular Degeneration.

Authors:  Fatimah Mohammad; Justin Wanek; Ruth Zelkha; Jennifer I Lim; Judy Chen; Mahnaz Shahidi
Journal:  J Ophthalmol       Date:  2014-10-13       Impact factor: 1.909

10.  ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.

Authors:  Alejandra Daruich; Alexandre Matet; Laetitia Marchionno; Jean-Dominique De Azevedo; Aude Ambresin; Irmela Mantel; Francine Behar-Cohen
Journal:  Retina       Date:  2017-10       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.